Foster Dykema Cabot & Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$410K Hold
2,787
0.03% 80
2025
Q4
$543K Sell
2,787
-112
-4% -$26.7K 0.03% 76
2025
Q3
$815K Buy
2,899
+140
+5% +$35.7K 0.05% 63
2025
Q2
$603K Buy
2,759
+1,024
+59% +$165K 0.04% 73
2025
Q1
$243K Sell
1,735
-95
-5% -$15.5K 0.02% 109
2024
Q4
$305K Hold
1,830
0.02% 107
2024
Q3
$312K Buy
1,830
+141
+8% +$20.4K 0.03% 102
2024
Q2
$238K Hold
1,689
0.02% 88
2024
Q1
$212K Sell
1,689
-95
-5% -$10.9K 0.02% 100
2023
Q4
$188K Buy
+1,784
New +$195K 0.02% 93

Other funds holding ORCL

Foster Dykema Cabot & Partners's ORCL Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its Oracle (ORCL) position steady in Q1 2026 at 2,787 shares worth $410K. The position accounts for 0.03% of the portfolio, ranked #80.

Foster Dykema Cabot & Partners first reported a position in ORCL in Q4 2023 and has held it in 10 quarters since. The position peaked at $815K in Q3 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Foster Dykema Cabot & Partners held 2,787 shares of Oracle worth $410K as of Q1 2026.
  • Foster Dykema Cabot & Partners left its Oracle share count unchanged in Q1 2026.
  • Oracle made up 0.03% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #80 holding.
  • Foster Dykema Cabot & Partners first reported a position in Oracle in Q4 2023 and has held it in 10 quarters since.
  • Foster Dykema Cabot & Partners's Oracle position peaked at $815K in Q3 2025.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.